| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹14.89 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹14.89 Cr |
| Fresh Issue | ₹14.00 Cr |
| Face Value | βΉ10 Per Equity Share |
| Price Band | βΉ78.00-82.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | MAITREYA |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,600 shares and in multiples thereof
Incorporated in 2019, Maitreya Medicare Limited is a multispeciality hospital situated in Surat, Gujrat. The main focus of the hospital is multi-disciplinary integrated healthcare services, with primary secondary & tertiary care. Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.
As of 2023, the hospital has a 125-bed capacity under the leadership of Dr. Narendra Singh Tanwar, founder, Promoter, CFO, and Managing Director of the hospital, Dr Pranav Rohitbhai Thaker, Promoter & whole-time director, and Mr. Vimal Patel, Promoter & Whole Time Director.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (βΉ Cr.) |
|---|---|---|
| 1 | Making investment through Equity in the subsidiary named βMaitreya Hospital Private Limitedβ for setting up Hospital at Valsad, Gujarat. | 7.50 |
| 2 | Redemption of part of issued Non-Convertible Redeemable Preference Shares | 1.00 |
| 3 | Funding the working capital requirements of the company | 5.00 |
| 4 | General Corporate Purposes | 0.74 |
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 31.22 | 27.50 | 24.49 | 25.27 |
| Total Income | 24.85 | 39.95 | 49.74 | 57.04 |
| Profit After Tax | 2.54 | 4.23 | 1.14 | 4.24 |
| NET Worth | 11.18 | 8.64 | 4.71 | 3.86 |
| Total Borrowing | 5.20 | 5.85 | 7.50 | 9.19 |
| Amount in ₹ Crore | ||||
| KPI | |
|---|---|
| ROE | 50.15% |
| ROCE | 42.71% |
| RoNW | 45.49% |
| PAT Margin | 14.80% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (βΉ) | 7.93 | |
| P/E (x) | 10.34 | 10.92 |
| Promoter Holding | 100% | 73.20% |
| Market Cap | βΉ55.56 Cr. | |